Skip to main navigation Skip to search Skip to main content

Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase

  • Laetitia Moreno Y. Banuls
  • , Adriana Katz
  • , Walter Miklos
  • , Alessio Cimmino
  • , Daniel M. Tal
  • , Elena Ainbinder
  • , Martin Zehl
  • , Ernst Urban
  • , Antonio Evidente
  • , Brigitte Kopp
  • , Walter Berger
  • , Olivier Feron
  • , Steven Karlish
  • , Robert Kiss (Corresponding author)

    Publications: Contribution to journalArticlePeer Reviewed

    Original languageEnglish
    Article number33
    Number of pages14
    JournalMolecular Cancer
    Volume12
    DOIs
    Publication statusPublished - 26 Apr 2013

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Austrian Fields of Science 2012

    • 301207 Pharmaceutical chemistry
    • 301204 Pharmacognosy

    Keywords

    • Cardiotonic steroids
    • Cardenolides
    • Bufadienolides
    • Cancer
    • Glycoside / aglycone forms
    • Lactate release - oxygen consumption
    • CARDIAC-GLYCOSIDES
    • SODIUM-PUMP
    • CARDIOTONIC STEROIDS
    • GENE-EXPRESSION
    • DRUG-DISCOVERY
    • UP-REGULATION
    • LUNG CANCERS
    • OUABAIN
    • CARCINOMA
    • DEATH

    Fingerprint

    Dive into the research topics of 'Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase'. Together they form a unique fingerprint.

    Cite this